Filing Flows

Filing Flows › Comparisons › CTSO vs UTMD

Cytosorbents vs Utah Medical Products: CTSO and UTMD compared

Cytosorbents is the larger company: $9.6M of revenue in its latest quarter (Q2 2026) against $8.5M for Utah Medical Products (Q2 2026). Cytosorbents is growing faster (+0.2% against -14% a year earlier). Utah Medical Products is more profitable, with an operating margin of 31.1% against -27.4%.

Cytosorbents vs Utah Medical Products, latest quarterCytosorbents vs Utah Medical Products, latest quarterCytosorbents (CTSO)Utah Medical Products (UTMD)Revenue$9.6M$8.5MRevenue growth, Y/Y+0.2%-14%Operating margin-27.4%31.1%Net margin-45.9%31.5%

Where the money goes: CTSO and UTMD

Cytosorbents (CTSO) · Q2 2026

Cytosorbents, Q2 2026: revenue $9.6M (+0.2% year over year), operating margin -27.4%, net loss $4.4M, operating cash flow −$583K. The chart follows the revenue to costs, profit and cash.

Utah Medical Products (UTMD) · Q2 2026

Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.

Utah Medical Products revenue by segment, Q2 2026Utah Medical Products revenue by segment, Q2 2026Gynecology/Electrosurgery/Urology$4.3MNeonatal$1.9MBlood Pressure Monitoring and Acc…$1.3MObstetrics$1.1M
Cytosorbents (CTSO)Utah Medical Products (UTMD)
Latest quarterQ2 2026Q2 2026
Revenue$9.6M$8.5M
Revenue growth, Y/Y+0.2%-14%
Gross margin—55.8%
Operating margin-27.4%31.1%
Net earnings−$4.4M$2.7M
Net margin-45.9%31.5%
Operating cash flow−$583K$1.4M
Free cash flow—$1.2M

Where the revenue comes from

Utah Medical Products

Questions

Which is bigger, Cytosorbents or Utah Medical Products?

Cytosorbents is the larger company: $9.6M of revenue in its latest quarter (Q2 2026) against $8.5M for Utah Medical Products (Q2 2026).

Is Cytosorbents or Utah Medical Products growing faster?

Cytosorbents is growing faster (+0.2% against -14% a year earlier).

Which is more profitable, Cytosorbents or Utah Medical Products?

Utah Medical Products is more profitable, with an operating margin of 31.1% against -27.4%.

More: Cytosorbents earnings · how Cytosorbents makes money · Utah Medical Products earnings · how Utah Medical Products makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.